Bringing the fundamentals into focus…
Back to QuidelOrtho Corporation
How QuidelOrtho Corporation stacks up
QDEL · against 484 other Healthcare companies of similar size
Valuation
64/ 100
Above the middle of the pack.
Ranked #183 of 485 · scores higher than 62% of peers
Bars: peers in each 10-point band of the valuation score37 peers with a valuation score of 60–69, including QDEL · Click a bar to see the companies
Why valuation scores 64?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its EBITDA yield, which is stronger than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -109.5% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -21.9% vs peer median 0.0%
- more operating profit (EBITDA) for the company's total value: stronger than 86% of peers. EBITDA yield: 12.4% vs peer median 4.0%
Metric by metric
Position: dot = QDEL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | QDEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 472 reported | -109.5% | 1.3% | 0% | 30% | |
| EBITDA yieldHigher is better · 491 reported | 12.4% | 4.2% | 86% | 50% | |
| Free cash flow yieldHigher is better · 206 reported | -21.9% | -2.4% | 8% | 20% | |
| Book yieldHigher is better · 481 reported | 184.4% | 41.5% | 98% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around QDELScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score